Price History

Hover for the daily close. The dotted line marks the period open.

Compare CV with… →

CV Key Statistics

As of Sep 4, 2026

Trading

Open: $5.93
Previous Close: $5.97
Day's Range: 5.92–6.09
52-Week Range: 3.43–15.37
Volume: 38.50K

Valuation

Market Cap: $299.78M
P/E Ratio: unprofitable
P/S ratio: 21.58
EPS (ttm): −1.11

Financials (FY)

Revenue (FY): $13.55M+15.29%
Net Income (FY): −$25.32M
Profit margin: −214.74%
Shares Outstanding: 50.05M
1-Year Return: +58.47%

Dividend and dates

Earnings Date: November 12, 2026
Avg Volume: 141.18K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CV Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	−43.97%
2025 (partial year)	+205.43%

As of September 4, 2026.

CV Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$13.55M	−$25.32M	−186.8%
2024	$11.76M	−$19.90M	−169.3%
2023	$9.75M	−$11.31M	−115.9%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$13.55M	$7.17M	−$25.52M	−$25.32M	−186.8%
2024	$11.76M	$6.38M	−$19.92M	−$19.90M	−169.3%
2023	$9.75M	$5.49M	−$11.35M	−$11.31M	−115.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CV Valuation vs Medical Devices Median

Median of 151 stocks

Metric	CV	Medical Devices median	vs median
P/S ratio	21.58	2.98	7.3x the median
Profit margin	−214.74%	−1.69%	213.0 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

CapsoVision, Inc. (CV) carries a market capitalisation of $299.78M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 99 employees.

The 52-week range on file runs from $3.43 to $15.37. CV last closed at $5.99 on September 4, 2026. That is +$0.02 (+0.34%) against the previous close. The latest close sits 74.43% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $13.55M. That is +15.29% against the prior fiscal year, when revenue was $11.76M. The same year closed with a net loss of $25.32M. The reported profit margin is −214.74%. That is 213 percentage points below the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −1.11.

Across the 3 fiscal years on file, revenue moves from $9.75M in 2023 to $13.55M in 2025. Of those 3 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 21.58 times revenue. On price-to-sales that is 7.3 times the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +58.47%. Annualized volatility over the trailing 1 year is 98.01%.

Growth & Income

No dividend is on file for CV.

So far in 2026 the price is −43.97%.

Peer Comparison

CapsoVision, Inc. (CV) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
CapsoVision, Inc.	CV	$299.78M	—
Abbott Laboratories	ABT	$187.45B	35.1
Medtronic plc.	MDT	$120.46B	22.9
Stryker Corporation	SYK	$116.27B	31.9

The Medical Devices industry average P/E ratio is 26.8x. CapsoVision, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

MDT

Medtronic plc.

$120.46B

SYK

Stryker Corporation

$116.27B

BSX

Boston Scientific Corporation

$69.27B

EW

Edwards Lifesciences Corporation

$51.82B

DXCM

DexCom, Inc.

$33.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About CapsoVision, Inc.

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

Visit website →

CapsoVision, Inc. (CV) Stock Analysis